Literature DB >> 26743950

Familial pachygyria in both genders related to a DCX mutation.

Young Ok Kim1, Tai-Seung Nam2, Chungoo Park3, Seul Kee Kim4, Woong Yoon4, Seok-Yong Choi5, Myeong-Kyu Kim2, Young Jong Woo6.   

Abstract

Doublecortin (DCX) and tubulin play critical roles in neuronal migration. DCX mutations usually cause anterior dominant lissencephaly in males and subcortical band heterotopia (SBH) in females. We used whole-exome sequencing to investigate causative gene variants in a large family with late-childhood-onset focal epilepsy and anterior dominant pachygyria without SBH in both genders. Two potential variants were found for the genes encoding DCX and beta tubulin isotype 1 (TUBB1). The novel DCX mutation (p.D90G, NP_000546.2) appeared to be a major causative variant, whereas the novel mutation of TUBB1 (p.R62fsX, NP_110400.1) was found only in patients with more-severe intellectual disability after gender matching. We report an unusual DCX-related disorder exhibiting familial pachygyria without SBH in both genders.
Copyright © 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DCX; Focal seizures; Genetics; Intellectual disability; Pachygyria

Mesh:

Substances:

Year:  2015        PMID: 26743950     DOI: 10.1016/j.braindev.2015.12.005

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  2 in total

Review 1.  Potential Role of Microtubule Stabilizing Agents in Neurodevelopmental Disorders.

Authors:  Sara Anna Bonini; Andrea Mastinu; Giulia Ferrari-Toninelli; Maurizio Memo
Journal:  Int J Mol Sci       Date:  2017-07-26       Impact factor: 5.923

Review 2.  Distinct Features of Doublecortin as a Marker of Neuronal Migration and Its Implications in Cancer Cell Mobility.

Authors:  Abiola A Ayanlaja; Ye Xiong; Yue Gao; GuangQuan Ji; Chuanxi Tang; Zamzam Abdikani Abdullah; DianShuai Gao
Journal:  Front Mol Neurosci       Date:  2017-06-28       Impact factor: 5.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.